Literature DB >> 8769125

Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase.

A L Drayer1, X Pesesse, F De Smedt, R Woscholski, P Parker, C Erneux.   

Abstract

Distinct inositol and phosphatidylinositol polyphosphate 5-phosphatases have recently been cloned. Primers were designated coding for highly conserved amino acid regions that are shared between sequences of 5-phosphatases. We used degenerate primers to amplify polymerase chain reaction products from rat brain cDNA. A product with a novel sequence was identified and used to clone a 4.9 kb cDNA from human placenta cDNA libraries (hp51CN). COS-7 cells transfected with a C-terminal truncated form of this cDNA showed an increase in Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3 hydrolyzing activity, but not in Ins(1,4,5)P3 5-phosphatase. Enzymatic activity was inhibited in the presence of 2,3-bisphosphoglycerate and p-hydroxymercuribenzoate. The presence of an SH2 domain and proline-rich sequence motifs within hp51CN suggests that this 5-phosphatase interacts with various proteins in signal transduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769125     DOI: 10.1006/bbrc.1996.1161

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.

Authors:  E Muraille; X Pesesse; C Kuntz; C Erneux
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling.

Authors:  M J Aman; S F Walk; M E March; H P Su; D J Carver; K S Ravichandran
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.

Authors:  Patrick Ehm; Marcus M Nalaskowski; Torsten Wundenberg; Manfred Jücker
Journal:  Nucleus       Date:  2015-02-27       Impact factor: 4.197

4.  Identification of an active site cysteine residue in human type I Ins(1,4,5)P3 5-phosphatase by chemical modification and site-directed mutagenesis.

Authors:  D Communi; C Erneux
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

5.  5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration.

Authors:  Honglu Zhang; Ju He; Tatiana G Kutateladze; Takahiro Sakai; Takehiko Sasaki; Nicolas Markadieu; Christophe Erneux; Glenn D Prestwich
Journal:  Chembiochem       Date:  2010-02-15       Impact factor: 3.164

6.  SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.

Authors:  Sylvie Giuriato; Xavier Pesesse; Stéphane Bodin; Takehiko Sasaki; Cécile Viala; Evelyne Marion; Joseph Penninger; Stéphane Schurmans; Christophe Erneux; Bernard Payrastre
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

Review 7.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  SHIP-1 increases early oxidative burst and regulates phagosome maturation in macrophages.

Authors:  Lynn A Kamen; Jonathan Levinsohn; Amy Cadwallader; Susheela Tridandapani; Joel A Swanson
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 9.  Phosphatidylinositolphosphate phosphatase activities and cancer.

Authors:  Simon A Rudge; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2015-08-24       Impact factor: 5.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.